{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:14:08Z","timestamp":1783581248475,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":2320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"European Society for Medical Oncology (ESMO) Translational Research Fellowship"},{"name":"Sanofi-aventis Netherlands BV"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1093\/annonc\/mdt124","type":"journal-article","created":{"date-parts":[[2013,3,23]],"date-time":"2013-03-23T03:06:54Z","timestamp":1364008014000},"page":"1762-1769","source":"Crossref","is-referenced-by-count":106,"title":["Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"T.H.","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Beukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.L.","family":"Beets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.D.","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wiggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Hospers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Havenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt124_bb0010","first-page":"CD006041","article-title":"Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer","volume":"1","author":"Ceelen","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/annonc\/mdt124_bb0015","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"Gerard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijrobp.2007.02.001","article-title":"Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: phase I trial results","volume":"68","author":"Czito","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdt124_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semradonc.2011.02.006","article-title":"Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy","volume":"21","author":"Czito","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0030","first-page":"1055","article-title":"Targeted therapy in rectal cancer","volume":"21","author":"Willett","year":"2007","journal-title":"Oncology (Williston Park)"},{"key":"10.1093\/annonc\/mdt124_bb0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncponc0813","article-title":"Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer","volume":"4","author":"Willett","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2010.08.005","article-title":"Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation for rectal cancer","volume":"82","author":"Dipetrillo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdt124_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2011.06.008","article-title":"Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer\u2013a two stage phase II clinical trial","volume":"102","author":"Resch","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0050","first-page":"718","article-title":"Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41\/07","volume":"3","author":"Helbling","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/DCR.0b013e318197939a","article-title":"The \u2018liver-first approach\u2019 for patients with locally advanced rectal cancer and synchronous liver metastases","volume":"52","author":"Verhoef","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1093\/annonc\/mdt124_bb0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/02841860310012301","article-title":"A systematic overview of radiation therapy effects in rectal cancer","volume":"42","author":"Glimelius","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","article-title":"Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy","volume":"72","author":"Bujko","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt124_bb0075","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0140-6736(86)92612-7","article-title":"Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision","volume":"2","author":"Quirke","year":"1986","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt124_bb0080","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt124_bb0085","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.2002.07.010","article-title":"Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control","volume":"20","author":"Nagtegaal","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jvir.2011.12.015","article-title":"Increase in volume of ablation zones during follow-up is highly suggestive of ablation site recurrence in colorectal liver metastases treated with radiofrequency ablation","volume":"23","author":"Kele","year":"2012","journal-title":"J Vasc Interv Radiol"},{"key":"10.1093\/annonc\/mdt124_bb0095","first-page":"1375","article-title":"Randomized phase II clinical trials","volume":"69","author":"Simon","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdt124_bb0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10434-001-0347-3","article-title":"Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal","volume":"8","author":"Adam","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0105","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","article-title":"Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates","volume":"16","author":"Folprecht","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0110","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2007.07.017","article-title":"Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group","volume":"43","author":"Nordlinger","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdt124_bb0115","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.bjc.6605259","article-title":"Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial","volume":"101","author":"Okines","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt124_bb0120","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1200\/JCO.2005.02.113","article-title":"Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921","volume":"23","author":"Bosset","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0125","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1245\/s10434-010-1506-1","article-title":"Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence","volume":"18","author":"de Campos-Lobato","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0b013e3182196e1f","article-title":"Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mdt124_bb0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0140","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mdt124_bb0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2009.07.1682","article-title":"Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer","volume":"78","author":"Yeo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdt124_bb0150","first-page":"71","article-title":"Preoperative chemoradiation with capecitabine in locally advanced rectal cancer","volume":"66","author":"de Bruin","year":"2008","journal-title":"Neth J Med"},{"key":"10.1093\/annonc\/mdt124_bb0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.radonc.2007.11.025","article-title":"Short-course preoperative radiotherapy with delayed surgery in rectal cancer\u2014a retrospective study","volume":"87","author":"Radu","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-8140(96)01867-1","article-title":"Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients","volume":"43","author":"Graf","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.radonc.2009.04.007","article-title":"Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity","volume":"92","author":"Hatfield","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/bjs.7796","article-title":"Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer","volume":"99","author":"Pettersson","year":"2012","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mdt124_bb0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1200\/JCO.2009.23.4450","article-title":"American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer","volume":"28","author":"Wong","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1245\/s10434-007-9478-5","article-title":"Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?","volume":"15","author":"Mulier","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0185","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1245\/ASO.2004.08.019","article-title":"Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections","volume":"11","author":"Elias","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0190","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/annonc\/mdm607","article-title":"A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity","volume":"19","author":"Tol","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0195","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1200\/JCO.2008.21.1771","article-title":"Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study","volume":"27","author":"Willett","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0200","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2009.02.037","article-title":"Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer","volume":"76","author":"Crane","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdt124_bb0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jso.20301","article-title":"Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab","volume":"91","author":"Scappaticci","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0210","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/bjs.5346","article-title":"Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary","volume":"93","author":"Mentha","year":"2006","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mdt124_bb0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/bjs.6947","article-title":"Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases","volume":"97","author":"Van der Pool","year":"2010","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mdt124_bb0220","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1002\/cncr.27567","article-title":"Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer","volume":"1","author":"Butte","year":"2012","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt124_bb0225","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ejso.2007.01.005","article-title":"Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis","volume":"33","author":"Malik","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1093\/annonc\/mdt124_bb0230","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00595-010-4471-1","article-title":"Risk factors for early recurrence after curative hepatectomy for colorectal liver metastases","volume":"41","author":"Yamashita","year":"2011","journal-title":"Surg Today"},{"key":"10.1093\/annonc\/mdt124_bb0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","article-title":"Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial","volume":"11","author":"Folprecht","year":"2010","journal-title":"Lancet Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419366645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419366645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/7\/1762\/13789585\/mdt124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T07:39:11Z","timestamp":1624693151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419366645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0923753419366645"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt124","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}